Anti-IL-17A treatment reduces serum inflammatory, angiogenic and tissue remodeling biomarkers accompanied by less synovial high endothelial venules in peripheral spondyloarthritis
Merlijn H. Kaaij(Amsterdam University Medical Centers), Sander W. Tas(Amsterdam University Medical Centers)
Cited by 15
Related Papers
Effects of B-cell directed therapy on the preclinical stage of rheumatoid arthritis: the PRAIRI study
|Annals of the Rheumatic Diseases|2018|289
Local treatment with the selective IκB kinase β inhibitor NEMO-binding domain peptide ameliorates synovial inflammation
|Arthritis Research & Therapy|2006|74
Tertiary Lymphoid Structures in Rheumatoid Arthritis
|American Journal Of Pathology|2015|43